Skip to content
Friday, November 6, 2026
Vision Digital Today

The Zimbabwean Government Declines ‘One-Sided’ US Health Aid Package Due to Data Fears

Health aid image
The proposed US funding was aimed at programmes for HIV/Aids treatment and prevention, tuberculosis, and malarial diseases.

Zimbabwe has declined a substantial American healthcare agreement worth 367 million US dollars (272 million pounds) over five years due to the United States' insistence on confidential biological samples.

This rejection came to light after a internal memorandum dated December was disclosed, indicating that Head of State Emmerson Mnangagwa deemed the deal was "skewed".

A government representative later stated that the US was requesting biological samples for scientific study and commercial gain but refused to guarantee the resulting advantages from any future vaccines.

"We are forced to start the difficult and regrettable process of scaling back our support in Zimbabwe," said US ambassador to Zimbabwe Pamela Tremont in a statement.

The US Embassy indicated the US had provided over $1.9bn for health programmes to Zimbabwe over the last two decades.

A physicians' group in Zimbabwe has called for further talks to find a deal suitable to both sides so the country's vital HIV treatment initiative can be sustained.

Wider Context

This development comes after a comparable case in neighbouring Kenya, where a high court halted a similar deal with the US following concerns were filed about the security of citizens' health data.

After resuming office recently, US President Donald Trump has reduced foreign aid and closed the US Agency for International Development (USAID).

The agency had managed aid for the American government, but Trump argued its spending was "inefficient" and his administration was seeking government-to-government agreements to boost transparency and accountability.

According to reports, Sixteen nations in Africa have so far agreed to similar health pacts, representing more than $18.3bn in new funding.

Details of the Rejected Deal

The funds for Zimbabwe was intended to gone towards "tackling HIV/Aids, tuberculosis, malaria, healthcare for mothers and children, and disease outbreak preparedness.

"It is our view this collaboration could have provided significant advantages for Zimbabwean communities, particularly the 1.2 million currently receiving antiretroviral therapy through US-supported programmes," the Ambassador added.

However, government spokesperson Nick Mangwana argued the arrangement was "unequal".

"Zimbabwe was being asked to share its genetic material and health information for a long time, with no corresponding guarantee of benefiting from any scientific breakthroughs – like vaccines, diagnostics, or treatments – that could result from that provided information," Mangwana explained.

"In essence, our nation would provide the basic resources for medical research with no assurance that the end products would be available to our citizens should a future pandemic arise."

Sovereignty and Global Health

He also said that the American exit from the global health body and its push of bilateral deals were undermining systems previously set up through the international health agency.

The spokesperson gave as an example its Pathogen Access and Benefit Sharing system created to manage future pandemics.

"This mechanism is intended to ensure that when a country contributes its samples, the resulting advantages – including vaccines and treatments – are distributed fairly, not monopolised solely by those with the funds to develop them."

Zimbabwe's reservations over the US deal "must not be interpreted as hostility towards the US," he added.

"We are open to further discussions with our US partners on how subsequent co-operation might be designed in a way that honours the sovereignty and interests of each country."

Medical Community Response

The Zimbabwe College of Public Health Physicians (ZCPHP) expressed it recognised the government's concerns, but suggested that negotiations need to persist since much of the country's Aids initiatives depended on external financing.

"In cases where technical issues arise, such as those involving data governance or implementation frameworks, these can frequently be resolved through technical clarification and negotiated safeguards," the group commented.

This impasse underscores the complex debate between receiving much-needed foreign assistance and protecting local interests in an ever more interconnected world.

Written by

Erik Nguyen

A tech journalist with over a decade of experience covering digital transformation and emerging technologies across Europe.

Vision Digital Today

Type to search articles.